Risk of malnutrition in patients with systemic sclerosis-associated interstitial lung disease treated with nintedanib

OBJECTIVE: To assess adverse events in relation to baseline body mass index (BMI) and the risk of malnutrition in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD) treated with nintedanib. METHODS: Among patients with SSc-ILD randomized to receive nintedanib or placebo...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Arthritis care & research (2010) 2023-08, Vol.75 (12), p.2501-2507
Hauptverfasser:	Volkmann, Elizabeth R, Mcmahan, Zsuzsanna H, Smith-Castro, Vanessa, Jouneau, Stéphane, Miede, Corinna, Alves, Margarida, Herrick, Ariane L
Format:	Artikel
Sprache:	eng
Schlagworte:	Life Sciences
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!